Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Unveils Plan To Boost Transparency To Industry

This article was originally published in The Tan Sheet

Executive Summary

FDA identified 19 steps to improve its communications with drug and medical device manufacturers, promising quicker responses to industry questions.

You may also be interested in...



Social Media Could Improve Compliance, Enforcement Transparency – FDA Report

FDA report on increasing public access to compliance and enforcement data recommends that the agency deploy new electronic tools and assess stakeholder need for mobile Web applications.

Social Media Could Improve Compliance, Enforcement Transparency – FDA Report

FDA report on increasing public access to compliance and enforcement data recommends that the agency deploy new electronic tools and assess stakeholder need for mobile Web applications.

Compliance Data Should Be Linked To Enforcement Results – FDA Task Force

FDA’s transparency task force proposes a multi-pronged approach to make the agency’s compliance and enforcement data more accessible and user-friendly online.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS104785

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel